Cell Culture World Congress 2016
Munich, Germany (February, 23 - 24, 2016)
We're getting an absolutely fantastic response to this year's Cell Culture World Congress 2016 in Munich next February.
In the past few weeks I've been excited to confirm these fantastic speakers:
- Dr Stefan Wildt, VP, Global Head Technical Research and Development, Cell- and Gene Therapies, Novartis
- Dr Lorenz Mayr, VP Reagents & Assay Development, AstraZeneca
- Bo Kara, Head Process Development, Advanced Therapy Delivery, GSK
- Dr Yang Yang, Staff Scientist, Late Stage Process Development, Genzyme Sanofi
- Dr Felipe Bedoya, Director, Product Development Laboratory, Translational Research Program, University of Pennsylvania
- Mark D. Angelino, SVP, Pharmaceutical Sciences, bluebird bio
- James Miskin, Chief Technical Officer, Oxford BioMedica
- Jamie Freeman, Product Manager, Horizon Discovery
- Josh Grieger, Co-founder and Vice President of Manufacturing, Bamboo Therapeutics
- Dr Michael Pohlscheidt, Site Director External Manufacturing, Head of Asia Pacific Region, Genentech Inc
- Dr Berthold Bödecker, Chief Scientist, Global Drug Discovery - Global Biologics Biotech Development, Bayer Pharma AG
- Dr Alain Bernard, Vice-President, Biopharmaceutical Process Sciences, UCB Pharma
- Prof Alois Jungbauer, Head of Bioprocess Engineering, BOKU
- Dr Herve Broly, VP of Biotech Process Science, Merck Serono
Brand new topics include: CRISPR, omics considerations for cell line development, Immunotherapy, Manufacture of next gen therapeutics, logistics for cell and gene therapies, and Outsourcing manufacture to Asia and the Pacific region.
If you book now you can save up to ?480 off the regular price, prices go up at the start of October.
Visit the Cell Culture World Congress 2016 website to view the preliminary agenda.
All the best,
Jessica Robinson
Conference Manager
Cell Culture World Congress 2016
E: Jessica.robinson@terrapinn.com
More: http://www.terrapinn.com/template/live/add2diary.aspx?e=8027
